Invention Grant
- Patent Title: Medicament for atrophy treatment or increasing cell growth
-
Application No.: US14651809Application Date: 2013-12-13
-
Publication No.: US09637529B2Publication Date: 2017-05-02
- Inventor: Rudolf Berger
- Applicant: SIMU TRADE CONSULTING GMBH & CO. LEASING KG
- Applicant Address: AT Vienna
- Assignee: SIMU TRADE CONSULTING GMBH & CO. LEASING KG
- Current Assignee: SIMU TRADE CONSULTING GMBH & CO. LEASING KG
- Current Assignee Address: AT Vienna
- Agency: Chalker Flores, LLP
- Agent Chainey P. Singleton; Edwin S. Flores
- Priority: EP12197192 20121214
- International Application: PCT/EP2013/076547 WO 20131213
- International Announcement: WO2014/090991 WO 20140619
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/47 ; A61K31/00 ; A61K38/17
Abstract:
The present invention provides SERF2, a nucleic acid encoding said SERF2 or a cell expressing SERF2 for use as a medicament, in particular for use for use in treating or preventing an atrophy disease or condition or for increasing cellular growth in a patient such as sarcopenia, cachexia, dystrophy, hypoplasia, hypotonia, or muscle loss, as well as in vitro methods suitable for cell culture proliferation and pharmaceutical compositions.
Public/Granted literature
- US20150307568A1 Medicament for atrophy treatment or increasing cell growth Public/Granted day:2015-10-29
Information query
IPC分类:
